
The Psychedelic Podcast
Suresh Muthukumaraswamy, Ph.D. - Rethinking Research: Novel Approaches to Studying LSD Microdosing
Dec 26, 2022
Dr. Suresh Muthukumaraswamy, lead researcher in the world's first LSD microdosing clinical trial, discusses the unique design of his experiment, challenges faced, and potential benefits. They explore therapy in psychedelic assisted psychotherapy, regulatory considerations, and the relationship between the Maori and plant medicines in New Zealand.
49:47
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- LSD microdosing showed significant positive effects on participants' well-being, creativity, and energy levels, emphasizing its potential therapeutic benefits.
- Research on LSD microdosing highlighted the importance of dosage titration, flexibility in dosing schedules, and the impact of different settings on the effects, paving the way for improving the microdosing experience.
Deep dives
Researching LSD Microdosing in a Naturalistic Setting
Dr. Suresh Kumaraswamy conducted a clinical trial on LSD microdosing in New Zealand, allowing participants to take LSD home with them. The trial involved 80 healthy volunteers who took either a placebo or LSD microdoses every third day for six weeks. They reported significant effects on their well-being, happiness, creativity, and energy levels on the days they took the LSD microdoses. The study also found that the setting in which the doses were taken, such as daily activities, had a clear impact on the effects. The research aims to provide evidence-based guidelines for LSD microdosing, and further studies are planned to explore the potential benefits of microdosing in depressed patients.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.